Literature DB >> 7829217

Effects of cytokine-mediated modulation of nm23 expression on the invasion and metastatic behavior of B16F10 melanoma cells.

R S Parhar1, Y Shi, M Zou, N R Farid, P Ernst, S T al-Sedairy.   

Abstract

The molecular mechanisms of tumor invasion and metastasis are yet to be fully elucidated. A potential tumor-metastasis-suppressor gene nm23 has been described in certain rodent and human tumors. In the present study, we examined the potential anti-invasive and anti-metastatic effect of nm23 gene in B16F10 cells, a malignant murine melanoma cell line. Transfection of nm23 gene into B16F10 melanoma cells resulted in significant suppression of the invasiveness and metastatic ability of melanoma cells and significantly enhanced the survival of tumor-bearing mice. B16F10 melanoma cells transfected with nm23 produced significantly less soluble ICAM-I and were more susceptible to LAK-cell-mediated cytotoxicity. Co-culture of B16F10 melanoma cells with IL-2 had no effect on nm23 expression, whereas treatment with PGE2, TNF-alpha and IFN-gamma resulted in down-regulation of nm23 expression. Concomitantly, in vivo treatment with TNF-alpha or IFN-gamma in experimental mice increased pulmonary metastases and lowered the overall survival period, as compared with IL-2 treatment alone. These results provide evidence that nm23, in addition to its anti-metastatic function, could also be involved in modulating tumor-target-structure expression, in down-regulating invasive potential and in production of soluble intracellular adhesion molecules. The down-regulation of nm23 by TNF-alpha, IFN-gamma and particularly by PGE2 warrants re-examination of current immunotherapeutic protocols and of the role played by PGE2 in tumor progression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7829217     DOI: 10.1002/ijc.2910600213

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  37 in total

1.  The mystery of nm23H1 in thyroid cancer.

Authors:  Y Shi; M Zou; N R Farid
Journal:  J Endocrinol Invest       Date:  2002 Jul-Aug       Impact factor: 4.256

2.  Two-component kinase-like activity of nm23 correlates with its motility-suppressing activity.

Authors:  P D Wagner; P S Steeg; N D Vu
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 3.  Translational approaches using metastasis suppressor genes.

Authors:  Diane Palmieri; Christine E Horak; Jong-Heun Lee; Douglas O Halverson; Patricia S Steeg
Journal:  J Bioenerg Biomembr       Date:  2006-08       Impact factor: 2.945

Review 4.  Clinical-translational approaches to the Nm23-H1 metastasis suppressor.

Authors:  Patricia S Steeg; Christine E Horak; Kathy D Miller
Journal:  Clin Cancer Res       Date:  2008-08-15       Impact factor: 12.531

5.  Suppression of human melanoma metastasis following introduction of chromosome 6 is independent of NME1 (Nm23).

Authors:  M E Miele; A De La Rosa; J H Lee; D J Hicks; J U Dennis; P S Steeg; D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

6.  MMTV-associated transcription factor binding sites increase nm23-H1 metastasis suppressor gene expression in human breast carcinoma cell lines.

Authors:  Taoufik Ouatas; Susan E Clare; Melanie T Hartsough; Abel De La Rosa; Patricia S Steeg
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

7.  Activation of naive xenogeneic but not allogeneic endothelial cells by human naive neutrophils: a potential occult barrier to xenotransplantation.

Authors:  F al-Mohanna; K Collison; R Parhar; A Kwaasi; B Meyer; S Saleh; S Allen; S al-Sedairy; D Stern; M Yacoub
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

8.  The metastatic suppressor Nm23-H1 interacts with EBNA3C at sequences located between the glutamine- and proline-rich domains and can cooperate in activation of transcription.

Authors:  Chitra Subramanian; Erle S Robertson
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 9.  Basic and translational advances in cancer metastasis: Nm23.

Authors:  Taoufik Ouatas; Massimiliano Salerno; Diane Palmieri; Patricia S Steeg
Journal:  J Bioenerg Biomembr       Date:  2003-02       Impact factor: 2.945

10.  Effect of inhibition of the lysophosphatidic acid receptor 1 on metastasis and metastatic dormancy in breast cancer.

Authors:  Jean-Claude A Marshall; Joshua W Collins; Joji Nakayama; Christine E Horak; David J Liewehr; Seth M Steinberg; Mary Albaugh; Fernando Vidal-Vanaclocha; Diane Palmieri; Maryse Barbier; Maximilien Murone; Patricia S Steeg
Journal:  J Natl Cancer Inst       Date:  2012-08-21       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.